Literature DB >> 10531174

Bronchiectasis in systemic diseases.

M Cohen1, S A Sahn.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10531174     DOI： 10.1378/chest.116.4.1063

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  21 in total

1.  Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis.

Authors:  Pieter C Goeminne; Patrick Verschueren; Hans Scheers; Lieven J Dupont
Journal:  Clin Rheumatol       Date:  2011-09-22       Impact factor: 2.980

2.  Organizing pneumonia: a rare pulmonary manifestation of well-controlled ulcerative colitis.

Authors:  Xiaoming Zhou; Yu Chen; Li Zhao
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

3.  Immunity status of invasive pulmonary aspergillosis patients with structural lung diseases in Chinese adults.

Authors:  Shuo Liang; Rong Jiang; Hai-Wen Lu; Bei Mao; Man-Hui Li; Cheng-Wei Li; Shu-Yi Gu; Jiu-Wu Bai; Jin-Fu Xu
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 4.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

5.  Deletion of airway cilia results in noninflammatory bronchiectasis and hyperreactive airways.

Authors:  Sandra K Gilley; Antine E Stenbit; Raymond C Pasek; Kelli M Sas; Stacy L Steele; May Amria; Marlene A Bunni; Kimberly P Estell; Lisa M Schwiebert; Patrick Flume; Monika Gooz; Courtney J Haycraft; Bradley K Yoder; Caroline Miller; Jacqueline A Pavlik; Grant A Turner; Joseph H Sisson; P Darwin Bell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

Review 6.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

Review 7.  Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.

Authors:  Katrine Fjaellegaard; Melda Dönmez Sin; Andrea Browatzki; Charlotte Suppli Ulrik
Journal:  Chron Respir Dis       Date:  2016-08-09       Impact factor: 2.444

8.  Predominant pathogen competition and core microbiota divergence in chronic airway infection.

Authors:  Geraint B Rogers; Christopher J van der Gast; David J Serisier
Journal:  ISME J       Date:  2014-07-18       Impact factor: 10.302

9.  Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity.

Authors:  R J Boyton; J Smith; M Jones; C Reynolds; L Ozerovitch; A Chaudhry; R Wilson; M Rose; D M Altmann
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

10.  Analysis of CFTR Gene Variants in Idiopathic Bronchiectasis in Serbian Children.

Authors:  Katarina Milosevic; Aleksandra Nikolic; Aleksandra Divac Rankov; Mila Ljujic; Branimir Nestorovic; Dragica Radojkovic
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2013-06       Impact factor: 1.349
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.